Two-drug antiretroviral regimens for HIV
- PMID: 37657789
- DOI: 10.1136/bmj-2022-071079
Two-drug antiretroviral regimens for HIV
Conflict of interest statement
Competing interests: We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: JT has received speaker fees by Gilead Sciences, and conference registration fees from ViiV healthcare. 'In October 2023, JT will be become a paid employee of ViiV healthcare. JG has received speakers fee from Janssen UK.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical